CERo Historical Income Statement

CEROW Stock   0.01  0.01  44.44%   
Historical analysis of CERo Therapeutics income statement accounts such as Interest Income of 121.5 K, Depreciation And Amortization of 2.8 K or Selling General Administrative of 2.7 K can show how well CERo Therapeutics Holdings performed in making a profits. Evaluating CERo Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CERo Therapeutics's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining CERo Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CERo Therapeutics is a good buy for the upcoming year.

CERo Therapeutics Net Income

(2,663.04)

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About CERo Income Statement Analysis

CERo Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CERo Therapeutics shareholders. The income statement also shows CERo investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

CERo Therapeutics Income Statement Chart

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of CERo Therapeutics. It is also known as CERo Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from CERo Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CERo Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
 2010 2022 2023 2024 (projected)
Interest Income986.7K142.1K127.9K121.5K
Net Interest Income986.7K142.1K127.9K121.5K

CERo Therapeutics income statement Correlations

1.00.560.850.29-0.991.00.730.81-0.90.73-0.99-0.960.73-0.68-0.26-0.71
1.00.560.850.29-0.991.00.730.81-0.90.73-0.99-0.960.73-0.68-0.26-0.71
0.560.560.91-0.58-0.490.57-0.090.94-0.790.98-0.49-0.580.980.23-0.940.18
0.850.850.91-0.23-0.80.860.31.0-0.950.98-0.8-0.840.98-0.19-0.73-0.24
0.290.29-0.58-0.23-0.310.290.86-0.280.13-0.42-0.31-0.14-0.42-0.860.79-0.83
-0.99-0.99-0.49-0.8-0.31-0.98-0.73-0.750.9-0.671.00.98-0.670.730.180.76
1.01.00.570.860.29-0.980.730.82-0.90.74-0.98-0.950.74-0.67-0.27-0.71
0.730.73-0.090.30.86-0.730.730.25-0.370.11-0.73-0.580.11-0.940.4-0.95
0.810.810.941.0-0.28-0.750.820.25-0.920.99-0.75-0.790.99-0.12-0.77-0.17
-0.9-0.9-0.79-0.950.130.9-0.9-0.37-0.92-0.90.90.95-0.90.360.570.41
0.730.730.980.98-0.42-0.670.740.110.99-0.9-0.67-0.741.00.01-0.85-0.04
-0.99-0.99-0.49-0.8-0.311.0-0.98-0.73-0.750.9-0.670.98-0.670.730.180.76
-0.96-0.96-0.58-0.84-0.140.98-0.95-0.58-0.790.95-0.740.98-0.740.610.30.65
0.730.730.980.98-0.42-0.670.740.110.99-0.91.0-0.67-0.740.01-0.85-0.04
-0.68-0.680.23-0.19-0.860.73-0.67-0.94-0.120.360.010.730.610.01-0.531.0
-0.26-0.26-0.94-0.730.790.18-0.270.4-0.770.57-0.850.180.3-0.85-0.53-0.49
-0.71-0.710.18-0.24-0.830.76-0.71-0.95-0.170.41-0.040.760.65-0.041.0-0.49
Click cells to compare fundamentals

CERo Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CERo Stock Analysis

When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.